{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T01:11:14Z","timestamp":1773709874301,"version":"3.50.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T00:00:00Z","timestamp":1756252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1007\/s10787-025-01909-5","type":"journal-article","created":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T14:11:15Z","timestamp":1756303875000},"page":"4883-4893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The potential role of carvedilol in COVID-19 management: perspective and take-away"],"prefix":"10.1007","volume":"33","author":[{"given":"Hayder M.","family":"Al-Kuraishy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6213-6582","authenticated-orcid":false,"given":"Maii A.","family":"Abdelnaby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-874X","authenticated-orcid":false,"given":"Marios","family":"Papadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2206-7236","authenticated-orcid":false,"given":"Athanasios","family":"Alexiou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7817-425X","authenticated-orcid":false,"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,27]]},"reference":[{"issue":"8","key":"1909_CR1","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ejheart.2007.04.006","volume":"9","author":"P Agostoni","year":"2007","unstructured":"Agostoni P, Contini M, Cattadori G et al (2007) Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant? Eur J Heart Fail 9(8):827\u2013833. https:\/\/doi.org\/10.1016\/j.ejheart.2007.04.006","journal-title":"Eur J Heart Fail"},{"key":"1909_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00183","volume":"6","author":"CM Ahmed","year":"2015","unstructured":"Ahmed CM, Larkin J 3rd, Johnson HM (2015) SOCS1 mimetics and antagonists: a complementary approach to positive and negative regulation of immune function. Front Immunol 6:183. https:\/\/doi.org\/10.3389\/fimmu.2015.00183","journal-title":"Front Immunol"},{"key":"1909_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2018.01.005","volume":"199","author":"T Ajam","year":"2018","unstructured":"Ajam T, Ajam S, Devaraj S et al (2018) Effect of carvedilol vs metoprolol succinate on mortality in heart failure with reduced ejection fraction. Am Heart J 199:1\u20136. https:\/\/doi.org\/10.1016\/j.ahj.2018.01.005","journal-title":"Am Heart J"},{"issue":"Suppl 8","key":"1909_CR4","first-page":"S157","volume":"71","author":"AK Al-Buhadily","year":"2021","unstructured":"Al-Buhadily AK, Hussien NR, Al-Niemi MS et al (2021) Misfortune and spy story in the neurological manifestations of Covid-19. J Pakistan Med Assoc 71(Suppl 8):S157\u2013S160","journal-title":"J Pakistan Med Assoc"},{"key":"1909_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.toxrep.2020.12.013","volume":"8","author":"N Alexandris","year":"2021","unstructured":"Alexandris N, Lagoumintzis G, Chasapis CT et al (2021) Nicotinic cholinergic system and COVID-19: in silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions. Toxicol Rep 8:73\u201383. https:\/\/doi.org\/10.1016\/j.toxrep.2020.12.013","journal-title":"Toxicol Rep"},{"key":"1909_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.642181","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Abdullah SM et al (2021a) Case report: Hyperbilirubinemia in Gilbert syndrome attenuates Covid-19-induced metabolic disturbances. Front Cardiovasc Med 8:642181. https:\/\/doi.org\/10.3389\/fcvm.2021.642181","journal-title":"Front Cardiovasc Med"},{"issue":"10","key":"1909_CR7","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1089\/vim.2021.0042","volume":"34","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L et al (2021b) Levamisole therapy in COVID-19. Viral Immunol 34(10):722\u2013725. https:\/\/doi.org\/10.1089\/vim.2021.0042","journal-title":"Viral Immunol"},{"key":"1909_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2021.174196","volume":"904","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Almulaiky YQ et al (2021c) Role of leukotriene pathway and montelukast in pulmonary and extrapulmonary manifestations of COVID-19: the enigmatic entity. Eur J Pharmacol 904:174196. https:\/\/doi.org\/10.1016\/j.ejphar.2021.174196","journal-title":"Eur J Pharmacol"},{"key":"1909_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.642822","volume":"12","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alqarni M et al (2021d) Pleiotropic effects of tetracyclines in the management of COVID-19: emerging perspectives. Front Pharmacol 12:642822. https:\/\/doi.org\/10.3389\/fphar.2021.642822","journal-title":"Front Pharmacol"},{"issue":"12","key":"1909_CR10","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1007\/s11033-021-06770-7","volume":"48","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ et al (2021e) Niclosamide for COVID-19: bridging the gap. Mol Biol Rep 48(12):8195\u20138202. https:\/\/doi.org\/10.1007\/s11033-021-06770-7","journal-title":"Mol Biol Rep"},{"issue":"11","key":"1909_CR11","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1007\/s11010-021-04232-z","volume":"476","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ et al (2021f) The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem 476(11):4161\u20134166. https:\/\/doi.org\/10.1007\/s11010-021-04232-z","journal-title":"Mol Cell Biochem"},{"key":"1909_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.649128","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Faidah H et al (2021g) The looming effects of estrogen in COVID-19: a rocky rollout. Front Nutr 8:649128. https:\/\/doi.org\/10.3389\/fnut.2021.649128","journal-title":"Front Nutr"},{"key":"1909_CR13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.749291","volume":"12","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Mostafa-Hedeab G et al (2021h) Effects of \u03b2-blockers on the sympathetic and cytokines storms in Covid-19. Front Immunol 12:749291. https:\/\/doi.org\/10.3389\/fimmu.2021.749291","journal-title":"Front Immunol"},{"key":"1909_CR14","doi-asserted-by":"publisher","first-page":"175909142110576","DOI":"10.1177\/17590914211057635","volume":"13","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Qusti S et al (2021i) Covid-19-induced dysautonomia: a menace of sympathetic storm. ASN Neuro 13:17590914211057636. https:\/\/doi.org\/10.1177\/17590914211057635","journal-title":"ASN Neuro"},{"key":"1909_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2021.108516","volume":"104","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA et al (2022a) Neutrophil extracellular traps (NETs) and COVID-19: a new frontiers for therapeutic modality. Int Immunopharmacol 104:108516. https:\/\/doi.org\/10.1016\/j.intimp.2021.108516","journal-title":"Int Immunopharmacol"},{"key":"1909_CR16","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.clnesp.2021.12.030","volume":"47","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, El-Saber Batiha G (2022b) The possible role of ursolic acid in COVID-19: a real game changer. Clin Nutr ESPEN 47:414\u2013417. https:\/\/doi.org\/10.1016\/j.clnesp.2021.12.030","journal-title":"Clin Nutr ESPEN"},{"issue":"6","key":"1909_CR17","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s10787-022-01027-6","volume":"30","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Batiha GE, Faidah H et al (2022c) Pirfenidone and post-COVID-19 pulmonary fibrosis: invoked again for realistic goals. Inflammopharmacology 30(6):2017\u20132026. https:\/\/doi.org\/10.1007\/s10787-022-01027-6","journal-title":"Inflammopharmacology"},{"key":"1909_CR18","doi-asserted-by":"publisher","first-page":"5977","DOI":"10.1038\/s41598-023-32211-5","volume":"13","author":"HM Al-Kuraishy","year":"2023","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alarfaj SJ et al (2023) Long COVID and risk of erectile dysfunction in recovered patients from mild to moderate COVID-19. Sci Rep 13:5977. https:\/\/doi.org\/10.1038\/s41598-023-32211-5","journal-title":"Sci Rep"},{"issue":"1","key":"1909_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23605","volume":"38","author":"HM Al-Kuraishy","year":"2024","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Eldahshan OA et al (2024) The possible role of nuclear factor erythroid-2-related factor 2 activators in the management of COVID-19. J Biochem Mol Toxicol 38(1):e23605. https:\/\/doi.org\/10.1002\/jbt.23605","journal-title":"J Biochem Mol Toxicol"},{"issue":"3","key":"1909_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.838","volume":"11","author":"BM Alomair","year":"2023","unstructured":"Alomair BM, Al-Kuraishy HM, Al-Gareeb AI et al (2023) Mixed storm in SARS-CoV-2 infection: a narrative review and new term in the Covid-19 era. Immunity Inflamm Dis 11(3):e838. https:\/\/doi.org\/10.1002\/iid3.838","journal-title":"Immunity Inflamm Dis"},{"key":"1909_CR21","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cyto.2016.09.004","volume":"88","author":"K Amirshahrokhi","year":"2016","unstructured":"Amirshahrokhi K, Khalili AR (2016) Carvedilol attenuates paraquat-induced lung injury by inhibition of proinflammatory cytokines, chemokine MCP-1, NF-\u03baB activation and oxidative stress mediators. Cytokine 88:144\u2013153. https:\/\/doi.org\/10.1016\/j.cyto.2016.09.004","journal-title":"Cytokine"},{"issue":"8","key":"1909_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0148868","volume":"11","author":"RF Ara\u00fajo J\u00fanior","year":"2016","unstructured":"Ara\u00fajo J\u00fanior RF, Garcia VB, Leit\u00e3o RF et al (2016) Carvedilol improves inflammatory response, oxidative stress and fibrosis in the alcohol-induced liver injury in rats by regulating Kuppfer cells and hepatic stellate cells. PLoS ONE 11(8):e0148868. https:\/\/doi.org\/10.1371\/journal.pone.0148868","journal-title":"PLoS ONE"},{"issue":"9","key":"1909_CR23","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.3390\/diagnostics12092051","volume":"12","author":"AO Babalghith","year":"2022","unstructured":"Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI et al (2022) The potential role of growth differentiation factor 15 in COVID-19: a corollary subjective effect or not? Diagnostics 12(9):2051. https:\/\/doi.org\/10.3390\/diagnostics12092051","journal-title":"Diagnostics"},{"issue":"7","key":"1909_CR24","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1097\/01.hjh.0000234116.17778.63","volume":"24","author":"WW Batenburg","year":"2006","unstructured":"Batenburg WW, van Esch JH, Garrelds IM et al (2006) Carvedilol-induced antagonism of angiotensin II: a matter of alpha1-adrenoceptor blockade. J Hypertens 24(7):1355\u20131363. https:\/\/doi.org\/10.1097\/01.hjh.0000234116.17778.63","journal-title":"J Hypertens"},{"key":"1909_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.sciaf.2021.e01084","author":"GE Batiha","year":"2021","unstructured":"Batiha GE, Al-Gareeb DAI, Qusti S et al (2021a) WITHDRAWN: common NLRP3 inflammasome inhibitors and COVID-19: divide and conquer. Sci African. https:\/\/doi.org\/10.1016\/j.sciaf.2021.e01084","journal-title":"Sci African"},{"issue":"24","key":"1909_CR26","doi-asserted-by":"publisher","first-page":"7565","DOI":"10.26355\/eurrev_202112_27456","volume":"25","author":"GE Batiha","year":"2021","unstructured":"Batiha GE, Shaheen HM, Al-Kuraishy HM et al (2021b) Possible mechanistic insights into iron homeostasis role of the action of 4-aminoquinolines (chloroquine\/hydroxychloroquine) on COVID-19 (SARS-CoV-2) infection. Eur Rev Med Pharmacol Sci 25(24):7565\u20137584. https:\/\/doi.org\/10.26355\/eurrev_202112_27456","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"1909_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-022-01891-2","volume":"19","author":"GE Batiha","year":"2022","unstructured":"Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Welson NN (2022) Pathophysiology of post-COVID syndromes: a new perspective. Virol J 19(1):158. https:\/\/doi.org\/10.1186\/s12985-022-01891-2","journal-title":"Virol J"},{"issue":"11","key":"1909_CR28","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1164\/rccm.201404-0644LE","volume":"189","author":"GR Budinger","year":"2014","unstructured":"Budinger GR, Mutlu GM (2014) \u03b22-agonists and acute respiratory distress syndrome. Am J Respir Crit Care Med 189(11):1448. https:\/\/doi.org\/10.1164\/rccm.201404-0644LE","journal-title":"Am J Respir Crit Care Med"},{"key":"1909_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.605908","volume":"11","author":"R Chang","year":"2020","unstructured":"Chang R, Mamun A, Dominic A, Le NT (2020) SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress. Front Physiol 11:605908. https:\/\/doi.org\/10.3389\/fphys.2020.605908","journal-title":"Front Physiol"},{"issue":"11","key":"1909_CR30","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1128\/JVI.00231-09","volume":"83","author":"H Changotra","year":"2009","unstructured":"Changotra H, Jia Y, Moore TN et al (2009) Type I and type II interferons inhibit the translation of murine norovirus proteins. J Virol 83(11):5683\u20135692. https:\/\/doi.org\/10.1128\/JVI.00231-09","journal-title":"J Virol"},{"issue":"6","key":"1909_CR31","doi-asserted-by":"publisher","first-page":"17","DOI":"10.24018\/ejmed.2021.3.6.1099","volume":"3","author":"S Chowdhury","year":"2021","unstructured":"Chowdhury S, Bappy MH, Chowdhury S et al (2021) COVID-19 induced cardiovascular complications and recent therapeutic advances. European Journal of Medical and Health Sciences 3(6):17\u201322. https:\/\/doi.org\/10.24018\/ejmed.2021.3.6.1099","journal-title":"European Journal of Medical and Health Sciences"},{"key":"1909_CR32","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3389\/fped.2020.00206","volume":"8","author":"E Ciaglia","year":"2020","unstructured":"Ciaglia E, Vecchione C, Puca AA (2020) COVID-19 infection and circulating ACE2 levels: protective role in women and children. Front Pediatr 8:206. https:\/\/doi.org\/10.3389\/fped.2020.00206","journal-title":"Front Pediatr"},{"issue":"10","key":"1909_CR33","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jacc.2021.07.003","volume":"78","author":"A Clemente-Morag\u00f3n","year":"2021","unstructured":"Clemente-Morag\u00f3n A, Mart\u00ednez-Milla J, Oliver E et al (2021) Metoprolol in critically ill patients with COVID-19. J Am Coll Cardiol 78(10):1001\u20131011. https:\/\/doi.org\/10.1016\/j.jacc.2021.07.003","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"1909_CR34","doi-asserted-by":"publisher","first-page":"255","DOI":"10.4103\/ijp.IJP_457_18","volume":"51","author":"GN Dakhale","year":"2019","unstructured":"Dakhale GN, Sharma VS, Thakre MN, Kalikar M (2019) Low-dose sodium valproate versus low-dose propranolol in prophylaxis of common migraine headache: a randomized, prospective, parallel, open-label study. Indian J Pharmacol 51(4):255\u2013262. https:\/\/doi.org\/10.4103\/ijp.IJP_457_18","journal-title":"Indian J Pharmacol"},{"issue":"12","key":"1909_CR35","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s12272-016-0833-6","volume":"39","author":"AH Eid","year":"2016","unstructured":"Eid AH, Abdelkader NF, Abd El-Raouf OM et al (2016) Carvedilol alleviates testicular and spermatological damage induced by cisplatin in rats via modulation of oxidative stress and inflammation. Arch Pharm Res 39(12):1693\u20131702. https:\/\/doi.org\/10.1007\/s12272-016-0833-6","journal-title":"Arch Pharm Res"},{"key":"1909_CR36","volume-title":"Analogue-based Drug Discovery III","author":"J Fischer","year":"2013","unstructured":"Fischer J, Ganellin CR, Rotella DP (2013) Analogue-based Drug Discovery III. Wiley-VCH Verlag GmbH & Co, KGaA"},{"issue":"4","key":"1909_CR37","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/S0002-9149(03)00658-1","volume":"92","author":"JW Fung","year":"2003","unstructured":"Fung JW, Yu CM, Yip G et al (2003) Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. Am J Cardiol 92(4):406\u2013410. https:\/\/doi.org\/10.1016\/S0002-9149(03)00658-1","journal-title":"Am J Cardiol"},{"issue":"36","key":"1909_CR38","doi-asserted-by":"publisher","first-page":"7512","DOI":"10.1523\/JNEUROSCI.0193-21.2021","volume":"41","author":"M Garcia Fragas","year":"2021","unstructured":"Garcia Fragas M, Gast\u00e3o Davanzo G (2021) Cross-talk between TNF-\u03b1 and Angiotensin II in the neural control of hypertension. J Neurosci 41(36):7512\u20137513. https:\/\/doi.org\/10.1523\/JNEUROSCI.0193-21.2021","journal-title":"J Neurosci"},{"issue":"22","key":"1909_CR39","doi-asserted-by":"publisher","first-page":"8630","DOI":"10.3390\/ijms21228630","volume":"21","author":"FS Giorgi","year":"2020","unstructured":"Giorgi FS, Biagioni F, Galgani A et al (2020) Locus coeruleus modulates neuroinflammation in Parkinsonism and dementia. Int J Mol Sci 21(22):8630. https:\/\/doi.org\/10.3390\/ijms21228630","journal-title":"Int J Mol Sci"},{"key":"1909_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cytogfr.2020.06.013","volume":"54","author":"B Goker Bagca","year":"2020","unstructured":"Goker Bagca B, Biray Avci C (2020) The potential of JAK\/STAT pathway inhibition by ruxolitinib in the treatment of COVID-19. Cytokine Growth Factor Rev 54:51\u201362. https:\/\/doi.org\/10.1016\/j.cytogfr.2020.06.013","journal-title":"Cytokine Growth Factor Rev"},{"key":"1909_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yjmcc.2020.05.007","volume":"144","author":"JM Grimes","year":"2020","unstructured":"Grimes JM, Grimes KV (2020) P38 MAPK inhibition: a promising therapeutic approach for COVID-19. J Mol Cell Cardiol 144:63\u201365. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.05.007","journal-title":"J Mol Cell Cardiol"},{"issue":"3","key":"1909_CR42","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1080\/08982104.2018.1529793","volume":"29","author":"TM Ibrahim","year":"2019","unstructured":"Ibrahim TM, Abdallah MH, El-Megrab NA, El-Nahas HM (2019) Transdermal ethosomal gel nanocarriers; a promising strategy for enhancement of anti-hypertensive effect of carvedilol. J Liposome Res 29(3):215\u2013228. https:\/\/doi.org\/10.1080\/08982104.2018.1529793","journal-title":"J Liposome Res"},{"issue":"Suppl","key":"1909_CR43","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1016\/j.ihj.2020.11.109","volume":"72","author":"S Jadhav","year":"2020","unstructured":"Jadhav S, Dash PK, Varyani R, Kini P (2020) Clinical and electrophysiological characteristics of patients diagnosed with bypass-tract associated arrhythmias from a tertiary care centre in South India. Indian Heart J 72(Suppl):S39\u2013S40. https:\/\/doi.org\/10.1016\/j.ihj.2020.11.109","journal-title":"Indian Heart J"},{"issue":"4","key":"1909_CR44","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/CM9.0000000000001106","volume":"134","author":"S Jin","year":"2020","unstructured":"Jin S, Dai J, Teng X, Wu YM (2020) Adverse effects of sympathetic activation should not be neglected during the coronavirus disease 2019 pandemic. Chin Med J 134(4):413\u2013414. https:\/\/doi.org\/10.1097\/CM9.0000000000001106","journal-title":"Chin Med J"},{"issue":"21","key":"1909_CR45","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1161\/01.CIR.0000066912.58385.DE","volume":"107","author":"L Kalinowski","year":"2003","unstructured":"Kalinowski L, Dobrucki LW, Szczepanska-Konkel M et al (2003) Third-generation beta-blockers stimulate nitric oxide release from endothelial cells through ATP efflux: a novel mechanism for antihypertensive action. Circulation 107(21):2747\u20132752. https:\/\/doi.org\/10.1161\/01.CIR.0000066912.58385.DE","journal-title":"Circulation"},{"key":"1909_CR46","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.bbi.2014.10.007","volume":"45","author":"K Kolmus","year":"2015","unstructured":"Kolmus K, Tavernier J, Gerlo S (2015) \u03b22-Adrenergic receptors in immunity and inflammation: stressing NF-\u03baB. Brain Behav Immun 45:297\u2013310. https:\/\/doi.org\/10.1016\/j.bbi.2014.10.007","journal-title":"Brain Behav Immun"},{"issue":"1","key":"1909_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/diseases9010017","volume":"9","author":"EM Kozlov","year":"2021","unstructured":"Kozlov EM, Ivanova E, Grechko AV et al (2021) Involvement of oxidative stress and the innate immune system in SARS-CoV-2 infection. Diseases 9(1):17. https:\/\/doi.org\/10.3390\/diseases9010017","journal-title":"Diseases"},{"issue":"6","key":"1909_CR48","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.pharep.2015.03.008","volume":"67","author":"VI Kozlovski","year":"2015","unstructured":"Kozlovski VI, Lomnicka M, Bartus M et al (2015) Anti-thrombotic effects of nebivolol and carvedilol: involvement of \u03b22 receptors and COX-2\/PGI2 pathways. Pharmacol Rep 67(6):1041\u20131047. https:\/\/doi.org\/10.1016\/j.pharep.2015.03.008","journal-title":"Pharmacol Rep"},{"issue":"1","key":"1909_CR49","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s11239-009-0318-2","volume":"29","author":"PY Lin","year":"2010","unstructured":"Lin PY, Shen HC, Chen CJ et al (2010) The inhibition in tumor necrosis factor-alpha-induced attenuation in endothelial thrombomodulin expression by carvedilol is mediated by nuclear factor-kappaB and reactive oxygen species. J Thromb Thrombolysis 29(1):52\u201359. https:\/\/doi.org\/10.1007\/s11239-009-0318-2","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"1909_CR50","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","volume":"41","author":"W Luo","year":"2020","unstructured":"Luo W, Li YX, Jiang LJ et al (2020) Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19. Trends Pharmacol Sci 41(8):531\u2013543. https:\/\/doi.org\/10.1016\/j.tips.2020.06.007","journal-title":"Trends Pharmacol Sci"},{"issue":"3","key":"1909_CR51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0301086","volume":"19","author":"TA Majrashi","year":"2024","unstructured":"Majrashi TA, El Hassab MA, Mahmoud SH et al (2024) In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2. PLoS ONE 19(3):e0301086. https:\/\/doi.org\/10.1371\/journal.pone.0301086","journal-title":"PLoS ONE"},{"issue":"4","key":"1909_CR52","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1161\/CIRCRESAHA.120.317447","volume":"127","author":"JD McFadyen","year":"2020","unstructured":"McFadyen JD, Stevens H, Peter K (2020) The emerging threat of (micro)thrombosis in COVID-19 and its therapeutic implications. Circ Res 127(4):571\u2013587. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.317447","journal-title":"Circ Res"},{"key":"1909_CR53","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.biopha.2018.10.005","volume":"108","author":"D Meng","year":"2018","unstructured":"Meng D, Li Z, Wang G et al (2018) Carvedilol attenuates liver fibrosis by suppressing autophagy and promoting apoptosis in hepatic stellate cells. Biomed Pharmacother 108:1617\u20131627. https:\/\/doi.org\/10.1016\/j.biopha.2018.10.005","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"1909_CR54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1165\/rcmb.2007-0198TR","volume":"38","author":"GM Mutlu","year":"2008","unstructured":"Mutlu GM, Factor P (2008) Alveolar epithelial beta 2-adrenergic receptors. Am J Respir Cell Mol Biol 38(2):127\u2013134. https:\/\/doi.org\/10.1165\/rcmb.2007-0198TR","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"12","key":"1909_CR55","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1164\/rccm.200404-470CP","volume":"170","author":"GM Mutlu","year":"2004","unstructured":"Mutlu GM, Koch WJ, Factor P (2004) Alveolar epithelial beta 2-adrenergic receptors: Their role in regulation of alveolar active sodium transport. Am J Respir Crit Care Med 170(12):1270\u20131275. https:\/\/doi.org\/10.1164\/rccm.200404-470CP","journal-title":"Am J Respir Crit Care Med"},{"key":"1909_CR56","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.48167","volume":"8","author":"CA Nash","year":"2019","unstructured":"Nash CA, Wei W, Irannejad R, Smrcka AV (2019) Golgi localized \u03b21-adrenergic receptors stimulate Golgi PI4P hydrolysis by PLC\u03b5 to regulate cardiac hypertrophy. Elife 8:e48167. https:\/\/doi.org\/10.7554\/eLife.48167","journal-title":"Elife"},{"key":"1909_CR57","unstructured":"National Center for Biotechnology Information. (2025). PubChem Compound Summary for CID 11419372, Carvedilol Hydrochloride. Retrieved March 26, 2025, from\u00a0https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Carvedilol-Hydrochloride"},{"issue":"2","key":"1909_CR58","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/S0735-1097(02)02711-0","volume":"41","author":"R Nishio","year":"2003","unstructured":"Nishio R, Shioi T, Sasayama S, Matsumori A (2003) Carvedilol increases the production of interleukin-12 and interferon-gamma and improves the survival of mice infected with the encephalomyocarditis virus. J Am Coll Cardiol 41(2):340\u2013345. https:\/\/doi.org\/10.1016\/S0735-1097(02)02711-0","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"1909_CR59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1538-7836.2005.01109.x","volume":"3","author":"AY Nossent","year":"2005","unstructured":"Nossent AY, Dai L, Rosendaal FR et al (2005) Beta 2 adrenergic receptor polymorphisms: association with factor VIII and von Willebrand factor levels and the risk of venous thrombosis. J Thromb Haemost 3(2):405\u2013407. https:\/\/doi.org\/10.1111\/j.1538-7836.2005.01109.x","journal-title":"J Thromb Haemost"},{"issue":"10","key":"1909_CR60","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/j.rec.2019.04.006","volume":"72","author":"E Oliver","year":"2019","unstructured":"Oliver E, Mayor F, D\u2019Ocon P (2019) Beta-blockers: historical perspective and mechanisms of action. Revista Espa\u00f1ola De Cardiolog\u00eda (English Edition) 72(10):853\u2013862. https:\/\/doi.org\/10.1016\/j.rec.2019.04.006","journal-title":"Revista Espa\u00f1ola De Cardiolog\u00eda (English Edition)"},{"issue":"2","key":"1909_CR61","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1006\/jmcc.2000.1303","volume":"33","author":"T Omura","year":"2001","unstructured":"Omura T, Yoshiyama M, Ishikura F et al (2001) Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. J Mol Cell Cardiol 33(2):307\u2013316. https:\/\/doi.org\/10.1006\/jmcc.2000.1303","journal-title":"J Mol Cell Cardiol"},{"issue":"10","key":"1909_CR62","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00210-021-02147-6","volume":"394","author":"H Onohuean","year":"2021","unstructured":"Onohuean H, Al-Kuraishy HM, Al-Gareeb AI et al (2021) Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol 394(10):2013\u20132021. https:\/\/doi.org\/10.1007\/s00210-021-02147-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"10","key":"1909_CR63","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","volume":"143","author":"D Pellegrini","year":"2021","unstructured":"Pellegrini D, Kawakami R, Guagliumi G et al (2021) Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation 143(10):1031\u20131042. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.051828","journal-title":"Circulation"},{"issue":"4","key":"1909_CR64","doi-asserted-by":"publisher","first-page":"L620","DOI":"10.1152\/ajplung.00309.2020","volume":"319","author":"A Porzionato","year":"2020","unstructured":"Porzionato A, Emmi A, Stocco E et al (2020) The potential role of the carotid body in COVID-19. Am J Physiol-Lung Cell Mol Physiol 319(4):L620\u2013L626. https:\/\/doi.org\/10.1152\/ajplung.00309.2020","journal-title":"Am J Physiol-Lung Cell Mol Physiol"},{"issue":"1","key":"1909_CR65","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1172\/JCI30012","volume":"117","author":"F Rochais","year":"2007","unstructured":"Rochais F, Vilardaga JP, Nikolaev VO et al (2007) Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol. J Clin Invest 117(1):229\u2013235. https:\/\/doi.org\/10.1172\/JCI30012","journal-title":"J Clin Invest"},{"key":"1909_CR66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cbi.2014.09.009","volume":"223","author":"BD Sahu","year":"2014","unstructured":"Sahu BD, Koneru M, Bijargi SR et al (2014) Chromium-induced nephrotoxicity and ameliorative effect of carvedilol in rats: involvement of oxidative stress, apoptosis and inflammation. Chem Biol Interact 223:69\u201379. https:\/\/doi.org\/10.1016\/j.cbi.2014.09.009","journal-title":"Chem Biol Interact"},{"issue":"5","key":"1909_CR67","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.3390\/jcm9051417","volume":"9","author":"C Sardu","year":"2020","unstructured":"Sardu C, Gambardella J, Morelli MB et al (2020) Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? a comprehensive evaluation of clinical and basic evidence. J Clin Med 9(5):1417. https:\/\/doi.org\/10.3390\/jcm9051417","journal-title":"J Clin Med"},{"key":"1909_CR68","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00171","volume":"6","author":"A Scanzano","year":"2015","unstructured":"Scanzano A, Cosentino M (2015) Adrenergic regulation of innate immunity: a review. Front Pharmacol 6:171. https:\/\/doi.org\/10.3389\/fphar.2015.00171","journal-title":"Front Pharmacol"},{"key":"1909_CR69","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.freeradbiomed.2021.06.018","volume":"172","author":"NS Sharif-Askari","year":"2021","unstructured":"Sharif-Askari NS, Sharif-Askari FS, Mdkhana B et al (2021) Upregulation of oxidative stress gene markers during SARS-COV-2 viral infection. Free Radic Biol Med 172:688\u2013698. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.06.018","journal-title":"Free Radic Biol Med"},{"key":"1909_CR70","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.ijbiomac.2019.05.162","volume":"135","author":"M Sharma","year":"2019","unstructured":"Sharma M, Sharma R, Jain DK, Saraf A (2019) Enhancement of oral bioavailability of poorly water soluble carvedilol by chitosan nanoparticles: optimization and pharmacokinetic study. Int J Biol Macromol 135:246\u2013260. https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.05.162","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"1909_CR71","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.amjms.2020.05.030","volume":"360","author":"C Skayem","year":"2020","unstructured":"Skayem C, Ayoub N (2020) Carvedilol and COVID-19: a potential role in reducing infectivity and infection severity of SARS-CoV-2. Am J Med Sci 360(3):300. https:\/\/doi.org\/10.1016\/j.amjms.2020.05.030","journal-title":"Am J Med Sci"},{"issue":"12","key":"1909_CR72","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.amjmed.2021.07.004","volume":"134","author":"M St\u00e5hlberg","year":"2021","unstructured":"St\u00e5hlberg M, Reistam U, Fedorowski A et al (2021) Post-COVID-19 tachycardia syndrome: a distinct phenotype of post-acute COVID-19 syndrome. Am J Med 134(12):1451\u20131456. https:\/\/doi.org\/10.1016\/j.amjmed.2021.07.004","journal-title":"Am J Med"},{"issue":"4","key":"1909_CR73","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1055\/s-0033-1351119","volume":"34","author":"RM Sweeney","year":"2013","unstructured":"Sweeney RM, Griffiths M, McAuley D (2013) Treatment of acute lung injury: current and emerging pharmacological therapies. Semin Respir Crit Care Med 34(4):487\u2013498. https:\/\/doi.org\/10.1055\/s-0033-1351119","journal-title":"Semin Respir Crit Care Med"},{"issue":"2","key":"1909_CR74","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1161\/01.HYP.0000254415.31362.a7","volume":"49","author":"E Takimoto","year":"2007","unstructured":"Takimoto E, Kass DA (2007) Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49(2):241\u2013248. https:\/\/doi.org\/10.1161\/01.HYP.0000254415.31362.a7","journal-title":"Hypertension"},{"issue":"1","key":"1909_CR75","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s13054-019-2562-y","volume":"23","author":"K Tan","year":"2019","unstructured":"Tan K, Harazim M, Tang B et al (2019) The association between premorbid beta blocker exposure and mortality in sepsis\u2014a systematic review. Crit Care 23(1):298. https:\/\/doi.org\/10.1186\/s13054-019-2562-y","journal-title":"Crit Care"},{"issue":"10","key":"1909_CR76","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2020-236561","volume":"13","author":"F Taza","year":"2020","unstructured":"Taza F, Zulty M, Kanwal A, Grove D (2020) Takotsubo cardiomyopathy triggered by SARS-CoV-2 infection in a critically ill patient. BMJ Case Rep 13(10):e236561. https:\/\/doi.org\/10.1136\/bcr-2020-236561","journal-title":"BMJ Case Rep"},{"issue":"6","key":"1909_CR77","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.3390\/cells9061383","volume":"9","author":"B Tomar","year":"2020","unstructured":"Tomar B, Anders HJ, Desai J, Mulay SR (2020) Neutrophils and neutrophil extracellular traps drive necroinflammation in COVID-19. Cells 9(6):1383. https:\/\/doi.org\/10.3390\/cells9061383","journal-title":"Cells"},{"issue":"2","key":"1909_CR78","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jjcc.2019.07.011","volume":"75","author":"S Toyoda","year":"2020","unstructured":"Toyoda S, Haruyama A, Inami S et al (2020) Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure. J Cardiol 75(2):140\u2013147. https:\/\/doi.org\/10.1016\/j.jjcc.2019.07.011","journal-title":"J Cardiol"},{"issue":"4","key":"1909_CR79","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ejhf.1320","volume":"21","author":"A van der Pol","year":"2019","unstructured":"van der Pol A, van Gilst WH, Voors AA, van der Meer P (2019) Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail 21(4):425\u2013435. https:\/\/doi.org\/10.1002\/ejhf.1320","journal-title":"Eur J Heart Fail"},{"issue":"8","key":"1909_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/bies.202000094","volume":"42","author":"N Vasanthakumar","year":"2020","unstructured":"Vasanthakumar N (2020) Beta-adrenergic blockers as a potential treatment for COVID-19 patients. BioEssays 42(8):e2000094. https:\/\/doi.org\/10.1002\/bies.202000094","journal-title":"BioEssays"},{"issue":"12","key":"1909_CR81","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.amjcard.2013.08.013","volume":"112","author":"FH Verbrugge","year":"2013","unstructured":"Verbrugge FH, Duchenne J, Bertrand PB et al (2013) Uptitration of renin-angiotensin system blocker and beta-blocker therapy in patients hospitalized for heart failure with reduced versus preserved left ventricular ejection fractions. Am J Cardiol 112(12):1913\u20131920. https:\/\/doi.org\/10.1016\/j.amjcard.2013.08.013","journal-title":"Am J Cardiol"},{"issue":"1\u20132","key":"1909_CR82","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jneuroim.2010.04.006","volume":"223","author":"J Wang","year":"2010","unstructured":"Wang J, Li J, Sheng X et al (2010) Beta-adrenoceptor mediated surgery-induced production of pro-inflammatory cytokines in rat microglia cells. J Neuroimmunol 223(1\u20132):77\u201383. https:\/\/doi.org\/10.1016\/j.jneuroim.2010.04.006","journal-title":"J Neuroimmunol"},{"issue":"2","key":"1909_CR83","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.gene.2014.06.003","volume":"547","author":"D Wang","year":"2014","unstructured":"Wang D, Chen Y, Jiang J et al (2014) Carvedilol has stronger anti-inflammation and anti-virus effects than metoprolol in murine model with coxsackievirus B3-induced viral myocarditis. Gene 547(2):195\u2013201. https:\/\/doi.org\/10.1016\/j.gene.2014.06.003","journal-title":"Gene"},{"issue":"3","key":"1909_CR84","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s11239-020-02297-z","volume":"51","author":"X Wang","year":"2021","unstructured":"Wang X, Sahu KK, Cerny J (2021) Coagulopathy, endothelial dysfunction, thrombotic microangiopathy and complement activation: potential role of complement system inhibition in COVID-19. J Thromb Thrombolysis 51(3):657\u2013662. https:\/\/doi.org\/10.1007\/s11239-020-02297-z","journal-title":"J Thromb Thrombolysis"},{"issue":"5","key":"1909_CR85","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","volume":"10","author":"C Wu","year":"2020","unstructured":"Wu C, Liu Y, Yang Y et al (2020) Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharm Sin B 10(5):766\u2013788. https:\/\/doi.org\/10.1016\/j.apsb.2020.02.008","journal-title":"Acta Pharm Sin B"},{"issue":"4","key":"1909_CR86","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s11739-020-02523-9","volume":"16","author":"A Yahyavi","year":"2021","unstructured":"Yahyavi A, Hemmati N, Derakhshan P et al (2021) Angiotensin enzyme inhibitors and angiotensin receptor blockers as protective factors in COVID-19 mortality: a retrospective cohort study. Intern Emerg Med 16(4):883\u2013893. https:\/\/doi.org\/10.1007\/s11739-020-02523-9","journal-title":"Intern Emerg Med"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01909-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-025-01909-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-025-01909-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T04:15:53Z","timestamp":1758082553000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-025-01909-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,27]]},"references-count":86,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1909"],"URL":"https:\/\/doi.org\/10.1007\/s10787-025-01909-5","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,27]]},"assertion":[{"value":"9 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors. This article does not contain any studies with human participants or animals performed by any of the authors. Therefore, ethical approval was not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable. This study did not involve any human participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable. This study does not contain individual-level data or images requiring consent for publication.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}